Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TOPAS, a network-based approach to detect disease modules in a top-down fashion. | NAR Genom Bioinform | 2022 | 36458021 | PubTator, text mining | PubMed |
| Update on gut microbiota in cardiovascular diseases. | Front Cell Infect Microbiol | 2022 | 36439214 | PubTator, text mining | PubMed |
| Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas. | Front Pharmacol | 2022 | 36438805 | PubTator, text mining | PubMed |
| Mo(vi) complexes of amide-imine conjugates for tuning the selectivity of fluorescence recognition of Y(iii) vs. Pb(ii). | RSC Adv | 2022 | 36425161 | PubTator, text mining | PubMed |
| Antiviral use in liver function abnormalities and Covid-19 patients: Serial cases. | Ann Med Surg (Lond) | 2022 | 36411832 | PubTator, text mining | PubMed |
| Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas. | Front Mol Neurosci | 2022 | 36407768 | PubTator, text mining | PubMed |
| Role of Human Aldo-Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene. | Chem Res Toxicol | 2022 | 36399404 | PubTator, text mining | PubMed |
| Complement C5 is a novel biomarker for liver metastasis of colorectal cancer. | J Gastrointest Oncol | 2022 | 36388659 | PubTator, text mining | PubMed |
| Prognosis prediction and tumor immune microenvironment characterization based on tryptophan metabolism-related genes signature in brain glioma. | Front Pharmacol | 2022 | 36386216 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development. | Drug Metab Rev | 2022 | 36369949 | PubTator, text mining | PubMed |
| SOD3 Expression in Tumor Stroma Provides the Tumor Vessel Maturity in Oral Squamous Cell Carcinoma. | Biomedicines | 2022 | 36359248 | PubTator, text mining | PubMed |
| Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. | Front Immunol | 2022 | 36341373 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Deletion of Constitutive Androstane Receptor Led to Intestinal Alterations and Increased Imidacloprid in Murine Liver. | J Endocr Soc | 2022 | 36320626 | PubTator, text mining | PubMed |
| Overview of Methotrexate Toxicity: A Comprehensive Literature Review. | Cureus | 2022 | 36312688 | PubTator, text mining | PubMed |
| Human ultrarare genetic disorders of sulfur metabolism demonstrate redundancies in H2S homeostasis. | Redox Biol | 2022 | 36306676 | PubTator, text mining | PubMed |
| Screening potential biomarkers of cholangiocarcinoma based on gene chip meta-analysis and small-sample experimental research. | Front Oncol | 2022 | 36300097 | PubTator, text mining | PubMed |
| Molybdenum Cofactor Deficiency in Humans. | Molecules | 2022 | 36296488 | PubTator, text mining | PubMed |
| Punicalagin Protects against the Development of Methotrexate-Induced Hepatotoxicity in Mice via Activating Nrf2 Signaling and Decreasing Oxidative Stress, Inflammation, and Cell Death. | Int J Mol Sci | 2022 | 36293191 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers?page=17